BMC Neurology BioMed Central Case report Open Access Androgen-induced cerebral venous sinus thrombosis in a young body builder: case report Mohammad Ali Sahraian*, Mahmood Mottamedi, Amir Reza Azimi and Babak Moghimi Address: Department of Neurology, Sina Hospital, Tehran University of Medical Sciences, Hassan Abad Square, Imam Khomini Street, Tehran, Iran Email: Mohammad Ali Sahraian* - msahrai@sina.tums.ac.ir; Mahmood Mottamedi - motamedi@sina.tums.ac.ir; Amir Reza Azimi - amirreza_azimi@yahoo.com; Babak Moghimi - moghimi@ams.ac.ir * Corresponding author Published: 03 December 2004 BMC Neurology 2004, 4:22 doi:10.1186/1471-2377-4-22 Received: 21 September 2004 Accepted: 03 December 2004 This article is available from: http://www.biomedcentral.com/1471-2377/4/22 © 2004 Sahraian et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: Cerebral venous sinus thrombosis is an infrequent disease with a variety of causes. Pregnancy, puerperium, contraceptive pills and intracranial infections are the most common causes. The patient may present with headache, focal neurological deficits and seizures. The clinical outcome is highly variable and treatment with heparin is advised. Case presentation: The patient is a 22 year old male who presented with headache, repeated vomiting and papilledema. He was a bodybuilder doing exercise since 5 years ago, who had used nandrolone decaonoate 25 milligrams intramuscularly during the previous 5 months. Brain MRI and MRV showed superior sagital and transverse sinus thrombosis and extensive investigations did not reveal any known cause. Conclusions: We suggested that androgen was the predisposing factor in our patient. Androgens may increase coagulation factors or platelet activity and cause arterial or venous thrombosis. As athletes may hide using androgens it should be considered as a predisposing factor for thrombotic events in such patients. Background Cerebral venous sinus thrombosis (CVST) is a disease with a wide spectrum of non specific clinical signs and symptoms, including headache, focal neurological deficits, seizures and coma. The clinical outcome is highly variable; patients may recover completely or may develop severe and lasting neurological deficits [1]. There are many causes for this disease but the most common predisposing factors are pregnancy, puerperium, contraceptive pills, coagulopathies and intracranial infections [2]. There are few reports of patients with CVST after androgen therapy. We present a young bodybuilder man who developed CVST with abusing androgens for increasing muscle mass. Page 1 of 6 (page number not for citation purposes) BMC Neurology 2004, 4:22 Case presentation In May 2004 a 22 year old male was admitted to our department with chief complaints of headache and vomiting. http://www.biomedcentral.com/1471-2377/4/22 Proaggregatory effect of testosterone and other synthetic androgens become more reliable theory for CVST, according to recent publication [6]. Conclusions The patient was well till 10 days prior to admission that developed progressive, intense bitemporal headache exacerbated with bending. The patient also had history of malaise, nausea and several episodes of vomiting from 3 days before admission. The only objective finding on physical examination was bilateral papilledema. The patient was a body builder doing exercise from 5 years ago who had used nandrolone decaonoate 25 mg once or twice a week during the last 5 months. He had injected 20 ampoules in this period. This case report presents a patient with CVST following exogenous androgen usage with a mechanism which is not completely understood, but it may be related to platelet activation or an increase in coagulation factors. As androgen use may be frequent and hidden in athletes, it may be an underestimated cause of cerebral venous thrombosis in young adults and careful history should be taken in these groups of patients. Lists of abbreviations CVST: cerebral venous sinus thrombosis Brain computed tomography without contrast was done for the patient which showed cord sign, emergency MR imaging including T1 – T2, weighted and MRV showed prominent superior sagital and transverse sinus thrombosis. The C.S.F opening pressure was 480 mm/H2o without any other abnormality. Heparin 80 IU/kg started as loading dose then continued 1000 IU/ hr for 10 days. On the 5th day of treatment headache resolved and warfarin added to heparin. PAI-1: Plasminogen activator inhibitor-1 Laboratory tests including antithrombin III activity, protein C, S factor V leiden, Plasma hemocystein and anticardiolipin were all within normal limits. Authors' contributions The patient was discharged in a good condition and was maintained on 6 months warfarin protcol. M.M : Revising the article. Discussion There are few reports of CVST following androgen therapy [3], but there is just one reported case of CVST in androgen using young body builder [4]. The anabolic activity of testosterone and its derivatives is primarily manifested in its myotrophic actions which result in greater muscle mass and strength. MRI: magnetic resonance imaging MRV: magnetic resonance venography Competing interests The author(s) declare that they have no competing interests. M.A.S: Admitting and treating the case, preparing the article. A.R.A : searching previous articles, preparing case presentation part. B.M : searching previous articles, preparing background. This has led to widespread use of androgenic anabolic steroids by athletes at all levels. Nandrolone decaonoate is a synthetic anabolic steroid. In focus on homeostasis system the most important factors under testosterone regulation are fibrinogen, Plasminogen activator inhibitor-1 (PAI – 1) and platelet aggregability. The current data indicate that testosterone lowers fibrinogen and PAI – 1, however these anticoagulatory and profibrinolytic may be opposed by proaggregatory effects on platelets because high dosages of androgens were found to decrease cycloxygenase activity and thereby increase platelet functions [5]. Page 2 of 6 (page number not for citation purposes) BMC Neurology 2004, 4:22 http://www.biomedcentral.com/1471-2377/4/22 Figure T1 weighted 1 horizontal nonGd Images show transverse sinus thrombosis T1 weighted horizontal nonGd Images show transverse sinus thrombosis. Page 3 of 6 (page number not for citation purposes) BMC Neurology 2004, 4:22 http://www.biomedcentral.com/1471-2377/4/22 Figure T1 weighted 2 sagital Images with Gd show thrombosis in sagital sinus T1 weighted sagital Images with Gd show thrombosis in sagital sinus. Page 4 of 6 (page number not for citation purposes) BMC Neurology 2004, 4:22 http://www.biomedcentral.com/1471-2377/4/22 Figure 2D MR venogram 3 shows sagital sinus thrombosis 2D MR venogram shows sagital sinus thrombosis. Page 5 of 6 (page number not for citation purposes) BMC Neurology 2004, 4:22 http://www.biomedcentral.com/1471-2377/4/22 Acknowledgements We are grateful to Mr. Hejrani for secretarial help and Mr. Solimani for preparing the photographs. It should be noted that written consent was obtained from the patient for publication of study. References 1. 2. 3. 4. 5. 6. Ameri A, Bousser MG: Cerebral venous sinus thrombosis. Neurol clin 1992, 10:87-111. Shelley Renowden : Cerebral Venous sinus thrombosis. Eur Radiol 2004, 14:215-26. Shiozawa Z, Yamada H, Mabuchic , Hotta T, saito M, Sobue I, Huang YP: Superior sagital sinus thrombosis associated with androgen therapy for hypoplastic anemia [abstract]. Ann Neurol 1982, 12:578-80. Jaillard AS, Hommel M, Mallaret M: Venous sinus thrombosis associated with androgens in a healthy young man [abstract]. Stroke 1994, 25:212-13. Shahidi NT: A review of the chemistry, biological action and clinical applications of anabolic androgenic steroids. Clin therap 2001, 23:1355-90. Wu FC, Von Eckardstein A: Androgens and coronary artery disease. Endocr Rev 2003, 24:183-217. Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2377/4/22/prepub Publish with Bio Med Central and every scientist can read your work free of charge "BioMed Central will be the most significant development for disseminating the results of biomedical researc h in our lifetime." Sir Paul Nurse, Cancer Research UK Your research papers will be: available free of charge to the entire biomedical community peer reviewed and published immediately upon acceptance cited in PubMed and archived on PubMed Central yours — you keep the copyright BioMedcentral Submit your manuscript here: http://www.biomedcentral.com/info/publishing_adv.asp Page 6 of 6 (page number not for citation purposes)